NCT07263243

Brief Summary

Obesity has become a major global public health issue, defined by an excessive accumulation of body fat that presents substantial health risks. Over 650 million adults worldwide suffer from obesity, which is defined as having a Body Mass Index (BMI) of 30 or higher. Obesity is becoming more common in both developed and developing countries. Sedentary lifestyles, unhealthy eating habits that include processed foods and sugars, and genetic factors are the main causes of the rising prevalence of obesity. Obesity is a multifactorial condition that affects physical appearance and self-esteem, while also having significant implications for long-term health, leading to decreased life expectancy and lower quality of life.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 4, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

January 24, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 24, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 24, 2026

Completed
Last Updated

December 12, 2025

Status Verified

December 1, 2025

Enrollment Period

1 month

First QC Date

November 23, 2025

Last Update Submit

December 5, 2025

Conditions

Overweight , Obesity

Outcome Measures

Primary Outcomes (3)

  • Brachial blood pressure

    Systolic brachial blood pressure and diastolic brachial blood pressure will be measured using a blood pressure (BP) monitoring device after 15 minutes rest.

    1 day

  • Heart rate

    Heart rate will be measured using a pulse oximeter after 15 minutes rest.

    1 day

  • Arterial O2 saturation

    Arterial oxygen saturation of pulse oximetry (SpO2) were measured using a pulse oximeter.

    1 day

Secondary Outcomes (2)

  • 6-Minute walk test

    1 day

  • The Borg scale

    1 day

Study Arms (2)

Study Group (Whole body vibration group)

EXPERIMENTAL

The study group (no = 13) underwent single session of whole-body vibration (WBV) of using the PowerPlate device.

Device: Whole-body vibration device

Control group (Sham whole body vibration group)

EXPERIMENTAL

The sham WBV group (no=13) will stand on the same device with the vibtation shut off for single session.

Other: Sham whole body vibration

Interventions

Sham whole body vibrationOTHER

A sham Whole body vibration will be used . participants will stand on the device without actual vibrations.This control condition will be used to isolate the effects of WBV from other potential influences such as standing posture and time spent on the the platform.

Control group (Sham whole body vibration group)
Whole-body vibration deviceDEVICE

Whole-body vibration (WBV) training using the Power Plate Pro 7HC (Northbrook, USA). The vibration frequency was set at 30 Hz, with an amplitude of 2 mm.

Study Group (Whole body vibration group)

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Females aged 18 to 25.
  • normotensive (\<140/90 mmHg).
  • Their BMI was from 25 to 40 kg/m2.
  • Sedentary (≤ 90min of regular exercise per week).

You may not qualify if:

  • Having previously diagnosed with any chronic disease.
  • Cardiorespiratory or neuromuscular conditions.
  • Participating in any exercise program.
  • Patients with a pacemaker.
  • Pregnancy.
  • Smoking.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jouf University

Jouf, Saudi Arabia

RECRUITING

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Rokaia Ali Toson Assistant Professor of Physical Therapy, Assistant Professor

CONTACT

+2/01061259678Rokaiazain@yahoo.com

Nesma Morgan Allam, Assistant Professor

CONTACT

+2 1281968332

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Physical Therapy

Study Record Dates

First Submitted

November 23, 2025

First Posted

December 4, 2025

Study Start

January 24, 2026

Primary Completion

February 24, 2026

Study Completion

February 24, 2026

Last Updated

December 12, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Locations

SA(1)